Compare stocks
Evaluate stocks side by side, to find the best fit for your investment goals.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
View stockRTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure across three segments, mostly as a supplier to commercial aerospace and to the defense market: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.
View stockStock highlights
Stock name | Nephros | RTX Corporation |
|---|---|---|
Last price | $3.31 | $198.36 |
Currency | USD | USD |
| $33M | $272B | |
| 17.27 | 32.72 | |
| $0.18 | $6.15 | |
| - | 0.31 | |
| 0 | $2.82 | |
| 0 | 1.45% | |
Sector | Industrials | Industrials |
Employees | 36 | 180,000 |
Ticker | $NEPH | $RTX |
Primary listing | NASDAQ | NYSE |
Performance
CumulativeRolling yearsLump sum investment
Invest in $NEPH or $RTX on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.